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Hospital-acquired bloodstream infections 
Hospital outbreaks of Pseudomonas 
aeruginosa and Acinetobacter baumannii 
bacteremic infections 
U. Frank. Institutfner Umweltmedizin nnd Krankcnhanshygiene, 
Lirtiversitaetskliniken Freiburz, Freibuv, Germany 
Pseudomonas aenrginosa and other non-fernrenting Gram-negative 
bacilli such as rlrinetobactcl- batrmannii have been recognized as 
important pathogens in hospital infections, with several reports of 
outbreaks in various settings. In epidemic situations, I! aeruginosa and 
A. baumannii have been noted to spread from contaminated common 
sources to persons as well as from person to person. The development 
of molecular typing methods has given the clinical microbiology 
laboratory powerful tools, thus providing the ineans for better 
understanding of the epidemiology of infections caused by these 
organisms. Bacteremia tends to occur in patents with impaired host 
defenses who have intravenous catheters and are receiving broad- 
spectrum antibiotics. While I! aenrginosa bacteremia is almost always 
life-threatening, bacteremia caused by A .  bairniannii has the dual 
potential to present as very low-grade infection or septic shock. I! 
aeruginosa and A. banmanriii isolates are resistant to many commonly 
used antibiotics, including first- and second-generation cephalo- 
sporins; only advanced beta-lactani antibiotics, aminoglycosides, and 
tluoroquinolones offer useful antimicrobial activity. Prevention and 
control of bacteremic infections caused by non-fermenting Gram- 
negative bacilli requires attention to many aspects of patient care and 
the hospital environment. 
w] A critical review of the efficacy of measures for 
preventing bloodstream infection 
R.C. Spencer. Public Health hborilfory, Brisfol Royal Ittfirmary, 
Brisfol, UK 
Over the past two decades the occurrence of bloodstream infections 
in hospitalized patients has increased. Gram-positive bacteria have 
emerged as the predominant nosocomial bloodstream infecting 
pathogens, while Gram-negative bacteria continue to decline. To 
compound these problems, antimicrobial resistance, long considered 
the domain of nosocomial Gram-negative microorganisms, is being 
increasingly exhibited by Gram-positive isolates. The attack rates for 
bloodstream infections range from 1.3 to 14.S per 1000 hospital 
admissions, varying with the type of patient population studied, 
underlying diseases, extremes of age, size of hospital, length of 
hospital stay, use of indwelling devices, ward location of the patient 
within a hospital and the prevalent types of infecting microorganisms. 
The evolving role of Gram-positive bloodstream infection is related 
to the high numbers of neutropenic/imniunocompromised patients, 
widespread use of indwelling vascular and urinary catheters, and 
increased use of antibiotics with anti-Gram-negative spectra. The risk 
factors specific to nosocomial bloodstream pathogens such as 
coagulase-negative staphylococci, MRSA, enterococci (especially 
VRE),and yeasts will be presented and discussed. The measures 
available for preventing nosocomial bloodstream infection include: 
the restriction of the use of broad-spectrum antibiotics; infection 
control measures; insertion and maintenance of intravascular and 
urinary catheters; advances in the design and constituents of in- 
dwelling catheters such as incorporation of metals, antiseptics or 
antibiotics; and the role of active surveillance of infecting micro- 
organisms and their antimicrobial susceptibility 
Towards an integrated molocular 
epidemiology of infectious diseases: 
epidemicity, virulence and host susceptibility 
markers 
Epidemicity and pathogenicity markers of 
Haemophilus influenzae 
A. van Belkum. Erasrnus Chiiiersity Medical Center Rotterdam, 
Departni~nf o Medical Microbiology G Injcrious Diseases, Rotterdam, 
The Nerlierlands 
Haemophilus intluenzae is of considerable clinical concern in specific 
groups of patients. For this reason, many investigations into its patho- 
genicity and epidemcity have been performed. The availability of 
the whole genome sequence has enabled these analyses to be per- 
formed in unprecedented detail. Complete sets of genes involved in 
the biosynthesis of virulence factors such as the lipopolysaccharide 
(LPS) could be identified and studied for their individual contri- 
bution to disease development in animal models of infection (Hood 
et al. Proc Natl Acad Sci USA 1996; 93: 11121-5). In addition, 
within the genome sequence potentially variable regions could be 
identified on the basis of the presence of repetitive DNA moieties. 
The usefulness for strain identification and tracking outbreak-related 
isolates of H .  iq'lnenzae of these loci was documented (Van Belkum 
et al. Infect Immun 1997; 65: 5017-27). In addition, it appeared that 
most if not all of the DNA reprat-containing regions were either in 
the close proximity of or even within the coding regions of potential 
virulence genes. The prime 'function' of the repeats lies in their 
potential to affect gene expression by altering either transcription 
efficiency or translational reading frames. Despite the functional con- 
straint posed upoii these regions, they still serve as useful molecular 
markers, in the end not only enabling the determination of evolu- 
tionary clock speed, but also facilitating the tracking of strains of H. 
intuenzae. The combination of assessing virulence characteristics and 
general genotypes might have important diagnostic medical- 
microbiological imphcations. 
Streptococcal toxic shock syndrome: virulent 
clones and/or susceptible host? 
M. Kotb. ICferans AJair, Medical Center, Memphis, TN, USA 
The numbers of streptococcal toxic shock (STSS) and necrotizing 
fasciitis (NF) cases continue to rise. Despite numerous studies, no 
satisfactory explanation for the renewed virulence of group A 
streptococci (GAS) has yet emerged-has the bacterium acquired 
new virulence and novel superantigens (SAP), or has host suscepti- 
bility been altered? These possibilities are not mutually exclusive; 
however, our recent studies of 300 cases showed that patients with 
invasive streptococcal infections, caused by genotypically indistin- 
guishable strains, can develop either severe (hypotension and multi- 
organ failure, e.g. STSS and STSS/NF) or non-severe invasive disease 
(no hypotension or organ failure, e.g. bacteremia/ceIlulitis). These 
observations strongly suggest that host factors play a pivotal role in 
determining the severity of systemic manifestations of invasive GAS 
infection. 
The pathogenesis of severe invasive GAS infections is believed to 
be mediated by streptococcal Sags, which together with streptococcal 
proteases can trigger potent release of inflammatory cytokinec that 
mediate tissue damage, organ failure, and shock. It is reasonable to 
propose that host factors that affect SAg responses are likely to 
modulate disease severity. The levels of antibodies (Abs) that can 
opsonize the bacteria or neutralize the activity of the SAgs that they 
